Biomarker testing is transforming lung cancer care and improving survival rates by helping doctors choose the most effective, personalized treatments for each patient. Through a tissue or blood test, doctors can identify specific genetic mutations or protein markers driving a person’s cancer. This information allows them to match patients with targeted therapies or immunotherapies that are far more effective and less toxic than traditional chemotherapy. Biomarker testing increases response rates, extends survival, and gives people living with lung cancer more time and better quality of life.
Be Your Own Advocate
Many patients don’t know they should ask for biomarker testing and it’s not always offered automatically. That’s why it’s so important to speak up and ask your doctor:
“Has my tumor been tested for biomarkers?”
“Should I wait for the results before starting treatment?”
“Am I eligible for targeted therapy or a clinical trial?”
Waiting for the results might take a couple of weeks but it’s worth it to get the right treatment from the start.
DON’T WAIT—talk to your care team about biomarker testing today.

